Clinicopathologic characteristics of NSCLC patients with uncommon EGFR mutations in Korea

被引：0
|
作者：
Kang, Hye Seon [1 ]
Kim, Kyu Yeon [2 ]
Lim, Jeong Uk [3 ]
Yeo, Chang Dong [4 ]
Kim, Ju Sang [5 ]
Kim, Seung Joon [6 ]
Lee, Sang Haak [4 ]
机构：
[1] Catholic Univ Korea, Bucheon St Marys Hosp, Resp & Crit Care Med, Bucheon, South Korea
[2] Catholic Univ Korea, Uijeongbu St Marys Hosp, Resp & Crit Care Med, Uijongbu, South Korea
[3] Catholic Univ Korea, Yeoiudo St Marys Hosp, Resp & Crit Care Med, Seoul, South Korea
[4] Catholic Univ Korea, Eunpyeong St Marys Hosp, Resp Sleep & Crit Care Med, Seoul, South Korea
[5] Catholic Univ Korea, Incheon St Marys Hosp, Resp & Crit Care Med, Incheon, South Korea
[6] Catholic Univ Korea, Seoul St Marys Hosp, Resp & Crit Care Med, Seoul, South Korea
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AO17-5
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [21] Hitting the Right Spot: Advances in the Treatment of NSCLC With Uncommon EGFR Mutations
    Sabari, Joshua K.
    Heymach, John V.
    Sandy, Beth
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 : S1 - S11
  • [22] Rationale and Design of a Phase II Trial of Dacomitinib in Advanced NSCLC Patients with Uncommon EGFR Mutations
    Han, B.
    Zhang, B.
    Shi, C.
    Gao, Z.
    Zhong, H.
    Xiong, L.
    Gu, A.
    Wang, W.
    Chu, T.
    Zhang, W.
    Wang, H.
    Zhang, X.
    Zhong, R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S613 - S613
  • [23] Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review
    Borgeaud, Maxime
    Parikh, Kaushal
    Banna, Giuseppe Luigi
    Kim, Floryane
    Olivier, Timothee
    Le, Xiuning
    Addeo, Alfredo
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : 973 - 983
  • [24] Efficacy of first-generation EGFR-TKIs on patients with NSCLC harboring EGFR uncommon mutations: a pooled analysis
    Zhang, Y.
    Tang, S.
    Zhang, J.
    He, Q.
    He, J.
    Liang, W.
    ANNALS OF ONCOLOGY, 2016, 27
  • [25] Activity of afatinib in patients with NSCLC harboring novel uncommon EGFR mutations with or without co-mutations: a case report
    Christopoulos, Petros
    Herster, Franziska
    Hoffknecht, Petra
    Falk, Markus
    Tiemann, Markus
    Kopp, Hans-Georg
    Althoff, Andre
    Stammberger, Anja
    Laack, Eckart
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [26] Clinical outcomes of gefitinib and erlotinib in patients with NSCLC harboring uncommon EGFR mutations: A pooled analysis of 438 patients
    Wang, Chunsheng
    Zhao, Kewei
    Hu, Shanliang
    Dong, Wei
    Gong, Yan
    Li, Minghuan
    Xie, Conghua
    LUNG CANCER, 2022, 172 : 86 - 93
  • [27] Investigating the Pathogenicity of Uncommon KRAS Mutations and Their Association with Clinicopathologic Characteristics in Patients with Colorectal Cancer
    Adorisio, Riccardo
    Ciardiello, Davide
    Rappa, Alessandra
    Gervaso, Lorenzo
    Pelizzari, Gloria
    Marinucci, Laura
    Fusco, Nicola
    Zampino, Maria Giulia
    Fazio, Nicola
    Venetis, Konstantinos
    Guerini-Rocco, Elena
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2025, 27 (02) : 130 - 138
  • [28] Safety and efficacy of aumolertinib treatment in patients with advanced NSCLC harboring uncommon EGFR mutations: Cohort 2
    Fang, W.
    Bu, Q.
    Wang, Q.
    Zhao, W.
    Wang, L.
    Dong, X.
    Chen, P.
    Wen, Z.
    Jia, J.
    Jiang, G.
    Zhang, L.
    ANNALS OF ONCOLOGY, 2022, 33 : S1587 - S1588
  • [29] Efficacy and safety of dacomitinib in treatment-naive patients with advanced NSCLC harboring uncommon EGFR mutations
    Wu, L.
    Pu, X.
    Zhou, Y.
    Kong, Y.
    Chen, B.
    Yang, A.
    Li, J.
    Li, K.
    Xu, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S1695 - S1695
  • [30] Afatinib for the Treatment of NSCLC Harboring Uncommon EGFR Mutations: A Database of 693 Cases
    Yang, James Chih-Hsin
    Schuler, Martin
    Popat, Sanjay
    Miura, Satoru
    Heeke, Simon
    Park, Keunchil
    Maerten, Angela
    Kim, Edward S.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (05) : 803 - 815
12345